Skip to main content
main-content

Devices and technology

Specific populations

03-08-2019 | Pregnancy | DUKPC 2019 | News

CONCEPTT data show substantial cost savings with CGM in pregnancy

Using continuous glucose monitoring for all women with type 1 diabetes during pregnancy could save the UK National Health Service over 9 million pounds per year, report the CONCEPTT investigators.

02-28-2019 | Mobile technology | News

Engagement with mobile health intervention linked to improved glycemic control

Responsiveness to text message reminders about blood glucose monitoring is associated with glycemic benefit among adolescents with type 1 diabetes, study findings indicate.

02-26-2019 | Psychosocial care | ATTD 2019 | News

CGM at diabetes diagnosis improves family psychosocial outcomes

Giving children continuous glucose monitoring from the point of diabetes diagnosis gives their caregivers greater confidence to manage hypoglycemia and reduces their diabetes-related distress, shows a randomized trial.

02-22-2019 | Continuous glucose monitoring | ATTD 2019 | Article

Researcher comment: The benefits of starting CGM immediately after diabetes diagnosis

Korey Hood discusses his research looking at the effects on patients and carers of starting continuous glucose monitoring straight after diabetes diagnosis (4:25).

02-22-2019 | Psychosocial care | ATTD 2019 | Article

Psychosocial research in diabetes: An endocrinologist’s viewpoint

Tim Jones explains why psychosocial research matters to clinicians, and discusses a randomized trial of continuous glucose monitoring from the point of diabetes diagnosis (3:11).

02-22-2019 | Psychosocial care | ATTD 2019 | Article

Expert highlights: Psychologic issues influencing device uptake in teens with diabetes

Korey Hood outlines some psychologic issues that should be addressed to optimize the uptake of diabetes technologies by adolescents (4:46).

02-01-2019 | Artificial pancreas systems | News

Support for hybrid closed-loop insulin delivery in young children

Home use of day and night hybrid closed-loop insulin delivery using the Cambridge model predictive control algorithm is feasible in children aged 1–7 years with type 1 diabetes, researchers report.

12-14-2018 | Artificial pancreas systems | News

MD-Logic closed-loop system successful for unmonitored day and night use

The DREAM5 randomized trial has confirmed the efficacy of closed-loop insulin delivery with the MD-logic algorithm in adolescents and young adults without remote monitoring.

12-14-2018 | Risk factors | Feature | Article

Sleep duration: Waking up to a major metabolic risk factor

The effect of sleep duration on glucose regulation and cardiometabolic risk is becoming an increasingly high-profile issue. medwireNews takes a look at the latest evidence, which shows the gravity of the problem but also offers some solutions.

11-07-2018 | Pregnancy | News

Surprising CONCEPTT findings on insulin pumps versus injections in pregnant women

A prespecified analysis of the CONCEPTT trial shows that pregnant women with type 1 diabetes who were using pumps at baseline did not achieve as good glycemic control as those using multiple daily injections.

10-04-2018 | Artificial pancreas systems | EASD 2018 | News

‘Gold standard’ trial tests closed-loop delivery across the age spectrum

A randomized trial demonstrates the efficacy of closed-loop insulin delivery in a wide range of patients with poorly controlled type 1 diabetes.

09-05-2018 | Older adults | Review | Article

Diabetes treatment in the elderly: Incorporating geriatrics, technology, and functional medicine

Valencia WM et al. Curr Diab Rep 2018; 18: 95. doi: 10.1007/s11892-018-1052-y

08-22-2018 | Insulin pumps | News

Predictive insulin-suspend algorithm cuts hypoglycemia without consequent hyperglycemia

The Tandem Basal-IQ predictive low-glucose suspend insulin delivery system significantly reduces the proportion of time adults and children spend in hypoglycemia during 24-hour usage, show findings from the randomized crossover PROLOG trial.

07-20-2018 | Insulin pumps | Article

Optimizing a hybrid closed loop system in type 1 diabetes: A case report

The authors present the optimization of a hybrid closed-loop insulin pump system in an 11-year-old female with 7 years of type 1 diabetes.

Petrovski G et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0473-6

07-31-2018 | Insulin pumps | News

Pros and cons of insulin pumps highlighted in young type 1 diabetes patients

Continuous subcutaneous insulin infusion therapy significantly lowers glycated hemoglobin levels in young people with type 1 diabetes, but at the cost of an increased risk for diabetic ketoacidosis during the first year, UK researchers report.

06-26-2018 | Devices and technology | Review | Article

Technology in the management of type 1 diabetes mellitus: Current status and future prospects

Tauschmann M Hovorka R. Nat Rev Rheumatol 2018. doi: 10.1038/s41574-018-0044-y

06-23-2018 | Type 1 diabetes | Review | Article

Closing the loop on managing youth with type 1 diabetes: Children are not just small adults

Sherr JL. Diabetes Care 2018. doi: 10.2337/dci18-0003

image credits